ExLibris header image
SFX Logo
Title: Plasma levels of lysophosphatidic acid in ovarian cancer versus controls: a meta-analysis
Source:

Lipids in Health and Disease [1476-511X] yr:2015


Collapse list of basic services Basic
Full text
Full text available via DOAJ Directory of Open Access Journals
GO
Full text available via PubMed Central
GO
Full text available via PubMed Central Open Access
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Rich, P. "More sensitive biomarker emerges for cancer detection: lysophosphatidic acid plasma levels higher in ovarian cancer patients." Medical Post 34.29 (1998): 23-. Link to SFX for this item
2. Baker, Daniel L L. "Plasma lysophosphatidic acid concentration and ovarian cancer." JAMA 287.23 (2002): 3081-3082. Link to SFX for this item
3. Murph, M. "Lysophosphatidic Acid-Induced Transcriptional Profile Represents Serous Epithelial Ovarian Carcinoma and Worsened Prognosis." PLoS ONE 4.5 (2009). Link to Full Text for this item Link to SFX for this item
4. Boucharaba, A. "Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer." The Journal of clinical investigation 114.12 (2004): 1714-1725. Link to Full Text for this item Link to SFX for this item
5. Hirayama, A. "Quantitative Metabolome Profiling of Colon and Stomach Cancer Microenvironment by Capillary Electrophoresis Time-of-Flight Mass Spectrometry." Cancer research 69.11 (2009): 4918-4925. Link to SFX for this item
6. Xu, Y. "Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers." JAMA 280.8 (1998): 719-723. Link to SFX for this item
7. Meleh, M. "Determination of serum lysophosphatidic acid as a potential biomarker for ovarian cancer." Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 858.1-2 (2007): 287-91. Link to SFX for this item
Select All Clear All

Expand list of advanced services Advanced